These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35994448)

  • 21. Cognitive Dysfunction, Psychiatric Distress, and Functional Decline After COVID-19.
    Vannorsdall TD; Brigham E; Fawzy A; Raju S; Gorgone A; Pletnikova A; Lyketsos CG; Parker AM; Oh ES
    J Acad Consult Liaison Psychiatry; 2022; 63(2):133-143. PubMed ID: 34793996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up.
    Mazza MG; Palladini M; De Lorenzo R; Magnaghi C; Poletti S; Furlan R; Ciceri F; ; Rovere-Querini P; Benedetti F
    Brain Behav Immun; 2021 May; 94():138-147. PubMed ID: 33639239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive Changes in Peritoneal Dialysis Patients: A Multicenter Prospective Cohort Study.
    Zhang YH; Yang ZK; Wang JW; Xiong ZY; Liao JL; Hao L; Liu GL; Ren YP; Wang Q; Duan LP; Zheng ZX; Dong J
    Am J Kidney Dis; 2018 Nov; 72(5):691-700. PubMed ID: 30007504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subjective and Objective Cognitive Impairments in Non-Hospitalized Persons 9 Months after SARS-CoV-2 Infection.
    Kirchberger I; Peilstöcker D; Warm TD; Linseisen J; Hyhlik-Dürr A; Meisinger C; Goßlau Y
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning.
    Whiteside DM; Basso MR; Naini SM; Porter J; Holker E; Waldron EJ; Melnik TE; Niskanen N; Taylor SE
    Clin Neuropsychol; 2022 May; 36(4):806-828. PubMed ID: 35130818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 infection and cognition in community-dwelling and nursing home residents in southern Switzerland.
    Rizzi G; Pacifico D; Sabatini S; Annoni AM; Mele F; Jovic S; Piccoli L; Corna L; Amati R; Pertoldi W; Fiordelli M; Sallusto F; Albanese E
    Brain Behav Immun Health; 2024 Feb; 35():100701. PubMed ID: 38107020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triage.
    Blackmon K; Day GS; Powers HR; Bosch W; Prabhakaran D; Woolston D; Pedraza O
    BMC Neurol; 2022 Jul; 22(1):285. PubMed ID: 35907815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-related cognitive impairment and wellbeing in patients with newly diagnosed aggressive lymphoma compared to population norms and healthy controls: an exploratory study.
    Gates P; Dhillon HM; Krishnasamy M; Wilson C; Gough K
    Support Care Cancer; 2024 Mar; 32(4):238. PubMed ID: 38512692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of oxygen therapy duration on cognitive impairment 12 months after hospitalization for SARS-COV-2 infection.
    Rapin A; Calmus A; Pradeau C; Taiar R; Belassian G; Godefroy O; Carazo-Mendez S; Boyer FC
    J Rehabil Med; 2023 Nov; 55():jrm12609. PubMed ID: 37974332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive phenotyping of post-infectious SARS-CoV-2 patients.
    Aiello EN; Radici A; Mora G; Pain D
    Neurol Sci; 2022 Aug; 43(8):4599-4604. PubMed ID: 35604618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results.
    Pirker-Kees A; Platho-Elwischger K; Hafner S; Redlich K; Baumgartner C
    Dement Geriatr Cogn Disord; 2021; 50(1):68-73. PubMed ID: 33853062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indices.
    Galderisi S; Perrottelli A; Giuliani L; Pisaturo MA; Monteleone P; Pagliano P; Vita A; Muiesan ML; Amore M; Bassetti M; Siracusano A; Mucci A; Bucci P; Cascino G; Barlati S; Amerio A; Di Lorenzo G; Niolu C; Coppola N; Maj M;
    Eur Neuropsychopharmacol; 2024 Feb; 79():22-31. PubMed ID: 38065006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive impairments among patients in a long-COVID clinic: Prevalence, pattern and relation to illness severity, work function and quality of life.
    Miskowiak KW; Pedersen JK; Gunnarsson DV; Roikjer TK; Podlekareva D; Hansen H; Dall CH; Johnsen S
    J Affect Disord; 2023 Mar; 324():162-169. PubMed ID: 36586593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurological and cognitive sequelae of Covid-19: a four month follow-up.
    Mattioli F; Stampatori C; Righetti F; Sala E; Tomasi C; De Palma G
    J Neurol; 2021 Dec; 268(12):4422-4428. PubMed ID: 33932157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and Determinants of Fatigue after COVID-19 in Non-Hospitalized Subjects: A Population-Based Study.
    Stavem K; Ghanima W; Olsen MK; Gilboe HM; Einvik G
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33669714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurologic and cognitive sequelae after SARS-CoV2 infection: Different impairment for ICU patients.
    Mattioli F; Piva S; Stampatori C; Righetti F; Mega I; Peli E; Sala E; Tomasi C; Indelicato AM; Latronico N; De Palma G
    J Neurol Sci; 2022 Jan; 432():120061. PubMed ID: 34894422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive consequences of COVID-19: results of a cohort study from South America.
    Crivelli L; Calandri I; Corvalán N; Carello MA; Keller G; Martínez C; Arruabarrena M; Allegri R
    Arq Neuropsiquiatr; 2022 Mar; 80(3):240-247. PubMed ID: 34816972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of COVID-19 infection on working memory: a systematic review.
    Cui R; Gao B; Ge R; Li M; Li M; Lu X; Jiang S
    Curr Med Res Opin; 2024 Feb; 40(2):217-227. PubMed ID: 38008952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of COVID-19: urging a need for multi-domain assessment of COVID-19 inpatients.
    Heyns A; Dupont J; Gielen E; Flamaing J; Peers K; Gosselink R; Vrijsen B; Lorent N; Everaerts S; Janssens W; Hermans G; Caluwé K; Staes B; Goeleven A; Meulemans A; Waelkens H; Beyens H; Tournoy J
    Eur Geriatr Med; 2021 Aug; 12(4):741-748. PubMed ID: 33786747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Greater executive dysfunction in patients post-COVID-19 compared to those not infected.
    Becker JH; Lin JJ; Twumasi A; Goswami R; Carnavali F; Stone K; Rivera-Mindt M; Kale MS; Naasan G; Festa JR; Wisnivesky JP
    Brain Behav Immun; 2023 Nov; 114():111-117. PubMed ID: 37586567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.